Dianthus Therapeutics, Inc.

Biotechnology company

DNTH Nasdaq SEC CIK 1690585

Follow Dianthus Therapeutics Weekly email: filings, results, news

News

6 stories filed under Dianthus Therapeutics, grouped into ongoing threads

Thread · 4 stories

Markets 36 d ago 2 sources

Markets 43 d ago

Markets 43 d ago

Markets 48 d ago 3 sources

Markets 19 d ago

Markets 31 d ago

NOV3

Q2 2026 results

Tuesday · estimated from the filing cadence

Profile · SEC EDGAR, Wikidata

Next results · estimated from the filing cadence (SEC EDGAR)

News · 6 stories clustered from the RSS aggregator